News headlines about Nobilis Health Corp (NYSE:HLTH) (TSE:NHC) have trended somewhat positive on Tuesday, according to Accern. Accern scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Nobilis Health Corp earned a coverage optimism score of 0.10 on Accern’s scale. Accern also assigned media coverage about the healthcare company an impact score of 0 out of 100, meaning that recent press coverage is extremely unlikely to have an impact on the stock’s share price in the near term.

These are some of the news headlines that may have impacted Accern’s scoring:

Shares of Nobilis Health Corp (NYSE HLTH) remained flat at $1.60 during midday trading on Tuesday. The company’s stock had a trading volume of 261,698 shares. The stock has a 50-day moving average price of $1.73 and a 200 day moving average price of $1.74. Nobilis Health Corp has a 52-week low of $1.10 and a 52-week high of $3.86. The company has a market capitalization of $124.49 million and a PE ratio of 13.79.

Nobilis Health Corp (NYSE:HLTH) (TSE:NHC) last released its quarterly earnings data on Wednesday, August 2nd. The healthcare company reported $0.02 EPS for the quarter, topping the consensus estimate of $0.01 by $0.01. The firm had revenue of $79.96 million for the quarter, compared to analysts’ expectations of $69.89 million. On average, equities research analysts expect that Nobilis Health Corp will post $0.14 earnings per share for the current fiscal year.

Nobilis Health Corp declared that its board has approved a stock repurchase program on Tuesday, May 2nd that permits the company to buyback 4,000,000 outstanding shares. This buyback authorization permits the healthcare company to purchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s leadership believes its stock is undervalued.

Several equities analysts have recently issued reports on HLTH shares. Zacks Investment Research cut Nobilis Health Corp from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 20th. Benchmark Co. assumed coverage on Nobilis Health Corp in a research note on Friday, May 19th. They set a “buy” rating and a $2.50 target price on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Nobilis Health Corp has a consensus rating of “Hold” and a consensus price target of $2.70.

WARNING: This story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at

About Nobilis Health Corp

Nobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company’s segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers.

Insider Buying and Selling by Quarter for Nobilis Health Corp (NYSE:HLTH)

Receive News & Stock Ratings for Nobilis Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nobilis Health Corp and related stocks with our FREE daily email newsletter.